PharmacoEconomics

Acknowledgement
pp. 991-993(3)
Author: Adis International Limited,

When NICE Says No!
pp. 995-996(2)
Author: Haycox, Alan

NICE Cost-Effectiveness Appraisal of Cholinesterase Inhibitors: Was the Right Question Posed? Were the Best Tools Used?
pp. 997-1006(10)
Authors: Getsios, Denis; Migliaccio-Walle, Kristen; Caro, Jaime J.

Recombinant Factor VIIa (Eptacog Alfa): A Pharmacoeconomic Review of its Use in Haemophilia in Patients with Inhibitors to Clotting Factors VIII or IX
pp. 1007-1029(23)
Authors: Lyseng-Williamson, Katherine A.; Plosker, Greg L.

Atorvastatin: A Pharmacoeconomic Review of its Use in the Primary and Secondary Prevention of Cardiovascular Events
pp. 1031-1053(23)
Authors: Plosker, Greg L.; Lyseng-Williamson, Katherine A.

Economic Evidence at the Local Level: Options for Making it More Useful
pp. 1055-1062(8)
Authors: Kees van Gool,; Gallego, Gisselle; Haas, Marion; Viney, Rosalie; Hall, Jane; Ward, Robyn

Oral Antiplatelet Therapy in Secondary Prevention of Cardiovascular Events: An Assessment from the Payer's Perspective
pp. 1063-1082(20)
Authors: Heeg, Bart; Damen, Joep; Ben Van Hout,